Game Changer Drug For COVID-19 : "COVIFOR" by Hetero Company

DCGI endorsed Hetero Pharmaceuticals for the supply of drug Covifor (Remdesivir) to various states where the many suspected or laboratory-confirmed COVID cases are hospitalized because of drastic symptoms of the Corona virus.

Hetero stated that Covifor (Remdesivir) will be provided in a 100 mg vial (injectable) and must be administered intravenously in a hospital or intensive care unit under the supervision of a healthcare practitioner.

Now domestic pharmaceutical giant Hetero has begun to provide 20,000 bottles of Covifor (Remdesivir) generic drugs nationwide. The cost of the product is Rs 5,400 per bottle

What is Covifor?

  • Covifor is a generic version of Remdesivir drug which can be used in emergency conditions of Corona cases

  • It is a drug whose first batch will be supplied to Delhi, Maharastra, Gujrat etc.

  • The company is sure about enough stock to provide to the present requirements of the drug. 

  • COVID-19 therapy by Covifor will cost less than 30,000 per patient. Six doses of the drug will be provided in the aforementioned timeframe. 

By Subham Singha (Science & Tech Division)
IGNITED MINDS


News & Image Source - Click here

THANK YOU

Comments

Popular posts from this blog

Shailene Woodley and Ansel Elgort are excited for Sushant's Dil Bechara

IIT-Gandhinagar team develops AI-based tool to detect COVID-19 using chest X-rays

10 Indian Web series You Shouldn't Miss